<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:15Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13148" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13148</identifier><datestamp>2026-10-18T21:13:28Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Investigation of the Role of Stimulation and Blockade of 5-HT7 Receptors in Ketamine Anesthesia.</dc:title><dc:creator>Dincer, Busra</dc:creator><dc:creator>Halici, Zekai</dc:creator><dc:creator>Cadirci, Elif</dc:creator><dc:subject>5-HT&lt;sub&gt;7&lt;/sub&gt; receptor</dc:subject><dc:subject>Anesthesia</dc:subject><dc:subject>Ketamine</dc:subject><dc:subject>NMDA receptor</dc:subject><dc:subject>Serotonin</dc:subject><dc:subject>Analgesics</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Hippocampus</dc:subject><dc:subject>Male</dc:subject><dc:subject>Mice</dc:subject><dc:subject>Mice, Inbred BALB C</dc:subject><dc:subject>Prefrontal Cortex</dc:subject><dc:subject>Receptors, N-Methyl-D-Aspartate</dc:subject><dc:subject>Receptors, Serotonin</dc:subject><dc:subject>Serotonin Antagonists</dc:subject><dc:subject>Serotonin Receptor Agonists</dc:subject><dc:subject>3 [2 [2 (4 methyl 1 piperidinyl)ethyl] 1 pyrrolidinesulfonyl]phenol</dc:subject><dc:subject>as 19</dc:subject><dc:subject>complementary DNA</dc:subject><dc:subject>messenger RNA</dc:subject><dc:subject>n methyl dextro aspartic acid receptor</dc:subject><dc:subject>n methyl dextro aspartic acid receptor 2A</dc:subject><dc:subject>n methyl dextro aspartic acid receptor 2B</dc:subject><dc:subject>serotonin 7 receptor</dc:subject><dc:subject>serotonin agonist</dc:subject><dc:subject>unclassified drug</dc:subject><dc:subject>analgesic agent</dc:subject><dc:subject>serotonin antagonist</dc:subject><dc:subject>serotonin receptor</dc:subject><dc:subject>animal experiment</dc:subject><dc:description>Although several pieces of evidence have indicated the ability of the serotonin-7 receptor (5-HTR7) to modulate N-methyl-D-aspartate receptor (NMDAR) activation, the possible impact on ketamine anesthesia has not been examined directly. The purpose of the present study is thus to investigate the possible role of the 5-HTR7 in ketamine anesthesia using a 5-HTR7 agonist and/or antagonist. The influence of a 5-HTR7 agonist/antagonist on ketamine anesthesia for behavioral impact was assessed by testing potential anesthetic parameters. Its functional impact was assessed by mRNA expression with real-time PCR and immunostaining in the hippocampus and prefrontal cortex of mice. Two different doses of ketamine—high and low—were administered to induce anesthesia. In the high-dose ketamine-applied group in particular, the administration of both the 5-HTR7 agonist and antagonist intensified the anesthetic effect of ketamine. The reflection of the change in anesthesia parameters to 5-HTR7 expression was observed as an increase in the hippocampus and a decrease in the prefrontal cortex in the anesthetized groups by stimulation of 5-HTR7. It is noteworthy that the results of NMDAR expressions are parallel to the results of the 5-HTR7 expressions of both the hippocampus and the prefrontal cortex. The 5-HTR7 may play a role in ketamine anesthesia. It may act through NMDAR in ketamine anesthesia, depending on the parallelism between both receptors. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.</dc:description><dc:publisher>Humana Press Inc.</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13148</dc:identifier><dc:identifier>https://doi.org/10.1007/s12031-020-01732-3</dc:identifier><dc:identifier>0895-8696</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Molecular Neuroscience</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13148</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>